Evidence map›Paper›PMID 25963964›Full record

ReviewNature reviews. Urology2015

Urinary considerations for adult patients with spinal dysraphism.

Paul W Veenboer, Laetitia M O de Kort, Rafal J Chrzan, Tom P V M de Jong

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Urology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Perspectives on urological care in spina bifida patients.Intractable & rare diseases research · 2021
    Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paul W VeenboerDepartment of Urology, University Medical Centre Utrecht, Room C.04.236, Heidelberglaan 100, P.O. Box 85500, 3584 CX, Utrecht, Netherlands.
Laetitia M O de KortDepartment of Urology, University Medical Centre Utrecht, Room C.04.236, Heidelberglaan 100, P.O. Box 85500, 3584 CX, Utrecht, Netherlands.
Rafal J ChrzanDepartment of Paediatric Urology Paediatric Renal Centre, Department of Paediatric Urology, University Children's Hospital, UMCU, P.O. Box 85090, 3508 AB, Utrecht, Netherlands.
Tom P V M de JongDepartment of Paediatric Urology Paediatric Renal Centre, Department of Paediatric Urology, University Children's Hospital, UMCU, P.O. Box 85090, 3508 AB, Utrecht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of newborns with spinal dysraphism is diminishing worldwide, although survival of individuals with this condition into adulthood continues to improve. The number of adults with spinal dysraphism will, therefore, increase in the coming years, which will pose new challenges in patient management. Urological manifestations of spinal dysraphism can include increased risks of urinary incontinence, urinary tract infection, urinary calculi, sexual dysfunction, end-stage renal disease and iatrogenic metabolic disturbances; however, the severity and incidence of these symptoms varies substantially between patients. Owing to the presence of multiple comorbidities, treatment and follow-up protocols often have to be adapted to best suit the needs of specific patients. Authors describe bladder and kidney function and long-term complications of treatments initiated in childhood, as well as the potential for improvements in quality of life through better follow-up schedules and future developments.

Indexed as

AdultHumansLower Urinary Tract SymptomsQuality of LifeSpina Bifida CysticaUrinary Bladder NeoplasmsUrinary Bladder, NeurogenicUrinary CalculiUrinary Tract InfectionsUrodynamics

Identifiers

PMID25963964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.